Logo

Zydus Lifesciences Share Price

Zydus Lifesciences (INR)1004.4-6.1   (-0.6%)

Exchange ScripsBSE532321NSEZYDUSLIFEISININE010B01027

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Zydus Lifesciences Performance

Market performance
Open price1009.05
High1019.1
Volumes2314182
Prev Close1004.4
Low1000.55
Closing date2025-01-10
Historical performance
1 Year High1324.30
3 Year High1324.30
5 Year High1324.30
1 Year Low686.00
3 Year Low319.00
5 Year Low202.00

Zydus Lifesciences Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
101026
Face Value
Face Value (₹)
1
P/E Ratio
P/E Ratio
26.18
Dividend Yield
Dividend Yield
0.3 %

Zydus Lifesciences Investment Returns

1 Year
42.1%
3 Years
121.4%
5 Years
289.1%
10 Years
197.7%

Zydus Lifesciences Technicals

IndicatorsValueSignal
5-DMA991.73Bullish
10-DMA982.77Bullish
20-DMA978.53Bullish
50-DMA974.39Bullish
100-DMA1027.46Bearish
200-DMA1052.27Bearish

Shareholding Pattern

FieldSep-2024Jun-2024Mar-2024Dec-2023Sep-2023
Promoters88888
Foreign Investors---------------
Domestic Investors88888
Public Investors370855336301294316306487297945
Government23323

Zydus Lifesciences Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income369447463907750
Operating Profit56684404653565434603
Interest812129912701864
Depreciation7641722771306696
Profit Before Tax48089258972838123992
Consolidated Net Profit38595196034487321336
Adjusted EPS38194421

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital1006101210241024
Total Reserves197289174146168972128899
Minority Interest22721217252054219373
Total Non-Current Liabilities1931-7250-1936194
Total Liabilities276366244940266996228103
Capital Work in Progress111151130266107832
Total Assets276366244940266996228103

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities32279268882104532939
Cash Flow from Investing Activities-1475215350-10003-7246
Cash Flow from Financing Activitie-18104-44004-8683-25477
Net Cash Inflow / Outflow-577-17662359216
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 26.18.
  • 3Y Stock Price CAGR of the stock is 31.0.
  • The stock has a beta of 0.7.
  • In the last financial year, the company had an EBITDA of ₹56684 Million.
  • The company generated revenue of ₹195474 Million in the previous financial year.

Zydus Lifesciences

1004.4-6.1   (-0.6%)

Investment Amount: ₹ 71685
Current Value: ₹ 100440
Performance: 40.1%
P/L: ₹ 28755
Top Gainers
SymbolChange%
NURECA380.7(18%)
CUBEXTUB96.84(16%)
MAZDA1969.9(14%)
ATLASCYCLE112.81(10%)
DNAMEDIA6.99(10%)
Top Losers
SymbolChange%
GTPL130.53(-11%)
GRWRHITECH4286.15(-10%)
SPANDANA405.8(-10%)
JAICORPLTD173(-10%)
AWL291.1(-10%)
DISHTV8.86(-10%)
HARRMALAYA284.45(-9%)
KAMDHENU46.4(-9%)
Similar stocks

Zota Health Care

52.3

994.45

December 12 - January 12

Medico Remedies

28.3

63.14

December 12 - January 12

Brooks Laboratories

26.2

182.06

December 12 - January 12

Bajaj Healthcare

18.8

536.65

December 12 - January 12

Nectar Lifesciences

14.3

38.25

December 12 - January 12

SMS Lifesciences

13.8

1301.8

December 12 - January 12

Blue Jet Healthcare

13.5

571.5

December 12 - January 12

Aarti Pharmalabs

10.5

669.5

December 12 - January 12

Announcing Stock of the Month!

Stock of the Month
Stock of the Month